≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Hodgkin lymphoma

Endpoint Browser PheWeb

CD2_HODGKIN_LYMPHOMA_EXALLC

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

None

-

2. Check conditions

None

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — C81
  • Hospital discharge: ICD-9 — 201
  • Cause of death: ICD-10 — C81
  • Cause of death: ICD-9 — 201

2 out of 7 registries used, show all original rules.

-

4. Check minimum number of events

None

-

5. Include endpoints

None

-

6. Filter based on genotype QC (FinnGen only)

None

-

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF12
Parent code in ICD-10
C81-C96
Name in latin
Morbus Hodgkin

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 1069 507 562
Unadjusted period prevalence (%) 0.21 0.17 0.25
Median age at first event (years) 44.62 36.88 51.60

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
949
Matched controls
9489
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
+∞
323.0
371
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
596.1
323.0
694
43
A03FA01
ATC
metoclopramide; systemic, rectal
23.3
323.0
559
549
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
323.0
329
*
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
+∞
323.0
481
*
JN4BD
NOMESCO Finland
Extensive body CT
36.9
297.1
390
176
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
526.5
283.8
269
7
L03AA02
ATC
filgrastim; parenteral
864.8
272.4
255
*
H02AB02
ATC
dexamethasone; systemic
136.3
270.0
280
29
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
60.0
253.9
296
71
A04AA02
ATC
granisetron; systemic, transdermal
2772.4
217.2
202
*
C81.0
ICD-10 Finland
Nodular lymphocyte predominant Hodgkin lymphoma
+∞
204.8
189
*
PJA10
NOMESCO Finland
Exploration of lymph nodes
275.1
180.3
179
8
A04AA01
ATC
ondansetron; systemic, rectal
32.4
165.2
221
88
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
85.7
163.7
181
26
XW000
NOMESCO Finland
Bone marrow biopsy
35.8
162.0
211
75
L03AA13
ATC
pegfilgrastim; parenteral
+∞
158.9
148
*
C81.7
ICD-10 Finland
Other classical Hodgkin lymphoma
+∞
150.1
140
*
C81.2
ICD-10 Finland
Mixed cellularity classical Hodgkin lymphoma
+∞
145.6
136
*
M04AA01
ATC
allopurinol; systemic
9.1
143.0
342
551
9663/3-C77.9
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of lymph node, NOS
+∞
135.7
127
*
JN4AD
NOMESCO Finland
Body CT examination
22.6
129.2
192
105
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
294.6
105.1
105
*
WF002
NOMESCO Finland
Radical radiotherapy
198.5
103.6
106
6
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
103.0
97
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
98.7
93
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
1040.1
97.8
94
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
524.0
97.3
95
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
96.5
91
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.2
92.6
552
2369
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
337.4
91.5
91
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
13.5
90.3
164
145
JN6AD
NOMESCO Finland
CT of torso and neck
148.8
89.8
94
7
9663/3-C77.8
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of lymph nodes of multiple regions
+∞
89.0
84
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
468.9
87.6
86
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
4.3
87.2
447
1642
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
918.5
87.1
84
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
84.9
82.8
92
12
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
10.2
82.1
172
201
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
858.7
81.7
79
*
A04AD12
ATC
aprepitant; systemic
846.8
80.6
78
*
R50.9
ICD-10 Finland
Fever, unspecified
5.6
79.9
270
633
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
77.1
73
*
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
84.9
76.5
85
11
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
76.1
72
*
ZX120
NOMESCO Finland
Intravenous
7.8
75.6
188
291
A49.9
ICD-10 Finland
Bacterial infection, unspecified
7.0
74.3
201
351
WW500
NOMESCO Finland
Blood transfusion
17.0
74.3
121
81
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
72.9
69
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
23.2
72.8
106
51
Z85.7
ICD-10 Finland
Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues
+∞
64.3
61
*
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
11.9
61.5
117
111
130
Kela drug reimbursment
Malignant tumour
+∞
61.1
58
*
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
322.1
60.0
60
*
9663/3-C77.0
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of lymph nodes of head, face and neck
+∞
57.9
55
*
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
59.9
57.5
67
12
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
56.8
54
*
XX3DW
NOMESCO Finland
Time consuming IT work
8.3
56.3
132
182
XX9CD
NOMESCO Finland
Very extensive complementary CT
+∞
55.8
53
*
J01MA12
ATC
levofloxacin; systemic
4.0
55.3
263
834
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
43.0
54.9
68
17
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
53.5
54.7
65
13
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
54.7
52
*
9650/3-C77.0
ICD-O-3
Hodgkin lymphoma, NOS, of lymph nodes of head, face and neck
+∞
52.6
50
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
52.6
50
*
2015X
ICD-9 Finland
Hodgkin's disease, Nodular sclerosis[MORBUS HODGKIN, NODULAR SCLEROSIS, NUD]
+∞
52.6
50
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
15.9
52.0
86
59
TPX10
NOMESCO Finland
Implantation of vascular injection port
17.8
51.8
82
50
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
49.4
47
*
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
175.7
48.3
50
*
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
109.9
48.3
52
5
ZX090
NOMESCO Finland
Other technic of radiotherapy
252.4
47.4
48
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
480.2
46.7
46
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.1
46.5
204
592
A02BC02
ATC
pantoprazole; systemic
2.7
45.8
645
4148
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
45.2
43
*
N02AA05
ATC
oxycodone; systemic
4.8
44.7
162
388
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
5.4
44.7
144
303
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.8
44.6
118
193
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.1
44.2
295
1190
WW300
NOMESCO Finland
Transfer of autologic stem cells
+∞
44.1
42
*
20199
ICD-8 Finland
Hodgkin's disease
+∞
44.1
42
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
436.2
42.5
42
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.7
42.2
210
675
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
42.0
40
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
42.0
40
*
PJA12
NOMESCO Finland
Sentinel node biopsy
425.2
41.5
41
*
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
219.4
41.2
42
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
40.9
39
*
1XC02
NOMESCO Finland
NA
56.0
40.9
48
9
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
112.5
40.1
43
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
208.5
39.1
40
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
392.4
38.3
38
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.8
38.1
308
1385
H02AB06
ATC
prednisolone; systemic
2.5
37.8
490
2872
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
17.9
37.6
59
35
Z51.5
ICD-10 Finland
Palliative care
15.3
37.3
62
43
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
10.2
37.1
75
79
TGC00
NOMESCO Finland
Bronchial lavation
12.1
36.8
68
60
UGC12
NOMESCO Finland
Flexible bronchoscopy
5.7
36.7
111
215
J05AB11
ATC
valaciclovir; oral
3.6
36.6
182
579
9652/3-C77.9
ICD-O-3
Hodgkin lymphoma, mixed cellularity, NOS, of lymph node, NOS
+∞
35.6
34
*
HA1AA
NOMESCO Finland
X-ray mammography
10.4
35.6
71
73
WZC30
NOMESCO Finland
Teaching
4.0
35.3
156
447
C81
ICD-10 Finland
Hodgkin lymphoma
359.9
35.2
35
*
TPH04
NOMESCO Finland
Cathetrisation of vein
3.0
34.8
237
944
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
4.3
34.8
139
363
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
6.8
34.7
91
146
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
+∞
34.6
33
*
9659/3-C77.9
ICD-O-3
Hodgkin lymphoma, nodular lymphocyte predominant of lymph node, NOS
+∞
34.6
33
*
9659/3-C77.8
ICD-O-3
Hodgkin lymphoma, nodular lymphocyte predominant of lymph nodes of multiple regions
+∞
34.6
33
*
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
+∞
34.6
33
*
115
Kela drug reimbursment
Breast cancer
+∞
33.5
32
*
JN4CD
NOMESCO Finland
Very extensive body CT
16.9
33.2
53
33
B01AB05
ATC
enoxaparin; parenteral
2.6
33.2
296
1392
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
121.0
32.9
35
*
C81.3
ICD-10 Finland
Lymphocyte depleted classical Hodgkin lymphoma
+∞
32.5
31
*
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
+∞
32.5
31
*
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
41.7
32.4
40
10
H02AB07
ATC
prednisone; oral
3.3
31.9
181
632
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.8
31.9
253
1105
H03AA01
ATC
levothyroxine sodium; systemic
2.8
31.8
251
1093
2019X
ICD-9 Finland
Hodgkin's disease, unspecified
+∞
31.4
30
*
ZX112
NOMESCO Finland
Subcutaneous
18.0
30.8
48
28
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
30.4
29
*
Z31.6
ICD-10 Finland
General counselling and advice on procreation
19.3
30.3
46
25
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
9.7
30.0
62
68
WX402
NOMESCO Finland
General anaesthesia
3.1
29.3
178
650
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
29.3
28
*
4701
FHL
Neck lymph node removal
106.7
28.8
31
*
C82.01
ICD-10 Finland
Follicular nodular lymphoma, grade I
+∞
28.3
27
*
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
6.5
28.1
75
123
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
43.9
27.9
34
8
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
99.6
26.8
29
*
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
19.8
26.7
40
21
D64.9
ICD-10 Finland
Anaemia, unspecified
3.8
26.5
119
343
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
26.2
25
*
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
27.9
25.9
35
13
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.7
25.8
198
835
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
5.2
25.7
82
168
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
25.1
24
*
9652/3-C77.8
ICD-O-3
Hodgkin lymphoma, mixed cellularity, NOS, of lymph nodes of multiple regions
+∞
25.1
24
*
A41.9
ICD-10 Finland
Sepsis, unspecified
6.3
24.3
66
111
L04.0
ICD-10 Finland
Acute lymphadenitis of face, head and neck
17.1
24.2
38
23
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
4.1
24.1
99
263
116
Kela drug reimbursment
Prostate cancer
+∞
24.1
23
*
9652/3-C77.0
ICD-O-3
Hodgkin lymphoma, mixed cellularity, NOS, of lymph nodes of head, face and neck
+∞
24.1
23
*
9650/3-C77.9
ICD-O-3
Hodgkin lymphoma, NOS, of lymph node, NOS
+∞
24.1
23
*
9650/3-C77.1
ICD-O-3
Hodgkin lymphoma, NOS, of intrathoracic lymph nodes
+∞
24.1
23
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.6
23.8
203
908
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
128.2
23.7
25
*
GEA00
NOMESCO Finland
Mediastinoscopy
55.5
23.2
27
5
C82.2
ICD-10 Finland
Follicular lymphoma grade III, unspecified
+∞
23.0
22
*
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
21.3
22.7
33
16
C83.00
ICD-10 Finland
Lymphocytic lymphoma
+∞
22.0
21
*
B72
ICPC
Hodgkin Lymphoma
+∞
22.0
21
*
WW402
NOMESCO Finland
Leucoferesis
+∞
22.0
21
*
ZX108
NOMESCO Finland
Inhalation
22.8
21.8
31
14
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
51.2
21.2
25
5
104
Kela drug reimbursment
Thyroid insufficiency
4.0
21.1
89
242
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
+∞
20.9
20
*
9663/3-C77.1
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of intrathoracic lymph nodes
+∞
20.9
20
*
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
+∞
20.9
20
*
2016A
ICD-9 Finland
Hodgkin's disease, Mixed cellularity
+∞
20.9
20
*
2014A
ICD-9 Finland
Hodgkin's disease, Lymphocytic-histiocytic predominance[MORBUS HODGKIN,""""LYMPHOCYTIC PREDOMINANCE"""",""""NODULAR""""]
+∞
20.9
20
*
7856A
ICD-9 Finland
Symptoms involving cardiovascular system, Enlargement of lymph nodes
214.4
20.7
21
*
GEA20
NOMESCO Finland
Mediastinoscopy with excision of lesion
42.7
20.5
25
6
WX110
NOMESCO Finland
Local anesthesy
2.0
20.4
663
5135
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
+∞
19.9
19
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
19.9
19
*
9680/3-C77.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph node, NOS
+∞
19.9
19
*
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
19.9
19
*
YNB10
NOMESCO Finland
Collection of stem cells for transplant
+∞
19.9
19
*
C03CA01
ATC
furosemide; systemic
2.2
19.8
240
1267
L02AE02
ATC
leuprorelin; implant, parenteral
11.6
19.6
36
32
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.7
19.2
67
152
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
19.0
258
1426
J01MA14
ATC
moxifloxacin; systemic
3.3
18.8
100
328
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
18.8
18
*
9659/3-C77.3
ICD-O-3
Hodgkin lymphoma, nodular lymphocyte predominant of lymph nodes of axilla or arm
+∞
18.8
18
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
18.8
18
*
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.8
18.6
126
484
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
102.1
18.6
20
*
WF004
NOMESCO Finland
Palliative radiotherapy
193.6
18.6
19
*
HAC20
NOMESCO Finland
Total mastectomy
44.9
18.3
22
5
C96.9
ICD-10 Finland
Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
+∞
17.8
17
*
2015A
ICD-9 Finland
Hodgkin's disease, Nodular sclerosis[MORBUS HODGKIN, NODULAR SCLEROSIS, CELLULAR PHASE]
+∞
17.8
17
*
2008X
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Other named variants
+∞
17.8
17
*
GD1AD
NOMESCO Finland
Thorax CT examination
4.7
17.5
60
134
TPX15
NOMESCO Finland
Removal of vascular injection port
29.4
17.5
23
8
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.4
17.3
87
274
212
Kela drug reimbursment
Gout
7.9
17.2
39
51
N02BE01
ATC
paracetamol; systemic, rectal
2.0
16.7
769
6465
D70.89
ICD-10 Finland
Neutropenic splenomegaly
15.4
16.7
27
18
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
16.7
16
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
+∞
16.7
16
*
C82.00
ICD-10 Finland
Follicular nodular non-Hodgkin's lymphoma, ungraded
+∞
16.7
16
*
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
16.7
16
*
A79
ICPC
Malignancy NOS
+∞
16.7
16
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.0
16.5
99
353
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
40.8
16.4
20
5
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
13.1
16.2
28
22
TPJ00
NOMESCO Finland
Biopsy of superficial lymph node
61.1
15.8
18
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
3.8
15.8
68
189
A07AA02
ATC
nystatin; oral
3.6
15.7
73
216
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.0
15.7
93
327
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
+∞
15.7
15
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
15.7
15
*
A04AA03
ATC
tropisetron; systemic
+∞
15.7
15
*
9663/3-C38.3
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of mediastinum, NOS
+∞
15.7
15
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
+∞
15.7
15
*
L01AA02
ATC
chlorambucil; oral
162.5
15.5
16
*
WW409
NOMESCO Finland
Other aferesis
162.5
15.5
16
*
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
29.1
15.2
20
7
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
7.3
15.2
36
51
I88.9
ICD-10 Finland
Nonspecific lymphadenitis, unspecified
20.4
15.1
22
11
B01AB10
ATC
tinzaparin; parenteral
4.1
15.1
59
150
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
8.7
15.1
32
38
J01DB01
ATC
cefalexin; oral
1.9
14.9
758
6419
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.7
14.9
484
3563
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.0
14.8
59
153
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
25.5
14.7
20
8
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
12.1
14.6
26
22
L01BC06
ATC
capecitabine; oral
+∞
14.6
14
*
1AA09
NOMESCO Finland
NA
+∞
14.6
14
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.7
14.6
64
181
B02.9
ICD-10 Finland
Zoster without complication
3.7
14.3
64
184
TPH07
NOMESCO Finland
Cathetrisation of artery
2.9
14.3
92
344
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
5.1
14.1
44
89
WW200
NOMESCO Finland
Immunization
5.5
14.0
41
77
WX002
NOMESCO Finland
Sedation and analgesia
2.1
13.7
173
914
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
76.2
13.6
15
*
TGD00
NOMESCO Finland
Needle biopsy of lung
76.2
13.6
15
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
13.6
13
*
9651/3-C77.9
ICD-O-3
Hodgkin lymphoma, lymphocyte-rich of lymph node, NOS
+∞
13.6
13
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
13.6
13
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
13.5
382
2672
C50.99
ICD-10 Finland
Breast, unspecified
141.9
13.5
14
*
AA1BD
NOMESCO Finland
Extensive CT of head and brain
6.6
13.5
34
53
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
5.0
13.2
42
87
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
7.7
13.2
30
40
I35.0
ICD-10 Finland
Aortic (valve) stenosis
3.3
12.8
64
201
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.8
12.7
277
1780
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
6.8
12.6
31
47
JN3AD
NOMESCO Finland
Abdominal CT examination
3.0
12.5
72
250
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
12.5
12
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
12.5
12
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
12.5
12
*
9651/3-C77.0
ICD-O-3
Hodgkin lymphoma, lymphocyte-rich of lymph nodes of head, face and neck
+∞
12.5
12
*
9659/3-C77.0
ICD-O-3
Hodgkin lymphoma, nodular lymphocyte predominant of lymph nodes of head, face and neck
+∞
12.5
12
*
9680/3-C77.8
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions
+∞
12.5
12
*
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
+∞
12.5
12
*
5702
FHL
Local lymph node removal (eg armpit, groin)
+∞
12.5
12
*
20298
ICD-8 Finland
Other neoplasms of lymphoid tissue, Lymphomata alia
+∞
12.5
12
*
JMA10
NOMESCO Finland
Transabdominal total splenectomy
38.1
12.2
15
*
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
18.3
12.1
18
10
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
27.1
12.1
16
6
I35.2
ICD-10 Finland
Aortic (valve) stenosis with insufficiency
5.0
11.8
37
76
R4110
NOMESCO Finland
Physiotherapy
1.8
11.8
218
1324
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
30.4
11.7
15
5
R06.0
ICD-10 Finland
Dyspnoea
1.8
11.7
211
1272
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
65.8
11.6
13
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.8
11.6
77
294
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
11.5
11
*
FM1FN
NOMESCO Finland
Heart function isotope examination
+∞
11.5
11
*
JAH21
NOMESCO Finland
Staging laparoscopy
+∞
11.5
11
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
11.5
11
*
6103
FHL
Staging laparotomy (to study the reticuloendothelial system)
+∞
11.5
11
*
L01BB05
ATC
fludarabine; systemic
+∞
11.5
11
*
9591/3-C77.0
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of head, face and neck
+∞
11.5
11
*
C85.7
ICD-10 Finland
Other specified types of non-Hodgkin lymphoma
+∞
11.5
11
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
11.5
11
*
ZXA05
NOMESCO Finland
Left side
1.8
11.4
212
1286
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
15.3
11.3
18
12
WX302
NOMESCO Finland
Thoracal epidural anesthesy
4.8
11.1
36
77
JAH01
NOMESCO Finland
Laparoscopy
3.8
11.1
46
125
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
5.9
11.1
30
52
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
43.8
10.9
13
*
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.5
10.8
50
149
121
Kela drug reimbursment
Severe hypofunction of sexual glands
5.7
10.8
30
54
JAH00
NOMESCO Finland
Laparotomy
5.1
10.7
33
67
ZXA00
NOMESCO Finland
Right side
1.8
10.7
218
1363
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
60.7
10.6
12
*
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
111.2
10.4
11
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
10.4
10
*
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
10.4
10
*
PJ4AT
NOMESCO Finland
Labeling lymphnode with ultrasound guidance
+∞
10.4
10
*
C83.35
ICD-10 Finland
T-cell-rich B-cell lymphoma
+∞
10.4
10
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
10.4
10
*
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
+∞
10.4
10
*
C90.0
ICD-10 Finland
Multiple myeloma
+∞
10.4
10
*
X76
ICPC
Malignant neoplasm breast female
+∞
10.4
10
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
10.4
208
1287
D69.5
ICD-10 Finland
Secondary thrombocytopenia
32.9
10.3
13
*
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
7.2
10.3
24
34
J05AB01
ATC
aciclovir; systemic
1.8
10.1
182
1089
UJF32
NOMESCO Finland
Coloscopy
1.8
10.1
190
1154
H02AB09
ATC
hydrocortisone; systemic
4.7
10.1
33
72
127
Kela drug reimbursment
Transplant complication
6.6
10.1
25
39
L57.0
ICD-10 Finland
Actinic keratosis
2.9
10.0
59
210
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
4.8
9.9
32
69
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
4.7
9.6
31
67
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
7.6
9.4
21
28
6753
FHL
Transabdominal splenectomy
101.0
9.4
10
*
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
+∞
9.4
9
*
1XC12
NOMESCO Finland
NA
+∞
9.4
9
*
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
+∞
9.4
9
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
+∞
9.4
9
*
9691/3-C77.9
ICD-O-3
Follicular lymphoma, grade 2 of lymph node, NOS
+∞
9.4
9
*
2009X
ICD-9 Finland
Lymphosarcoma and reticulosarcoma[LYMPHOMA MALIGNUM (NON-HODGKIN) NUD]
+∞
9.4
9
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
9.4
9
*
9650/3-C77.8
ICD-O-3
Hodgkin lymphoma, NOS, of lymph nodes of multiple regions
+∞
9.4
9
*
JAH20
NOMESCO Finland
Staging laparotomy
+∞
9.4
9
*
JFB30
NOMESCO Finland
Right hemicolectomy
21.9
9.4
13
6
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
4.1
9.3
35
88
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.3
9.2
90
422
I50.9
ICD-10 Finland
Heart failure, unspecified
2.1
9.1
107
545
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
10.2
9.0
17
17
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
37.0
9.0
11
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
24.3
8.9
12
5
A02BC01
ATC
omeprazole; systemic
1.7
8.8
225
1490
XF400
NOMESCO Finland
ECG with 12 standard connections
1.9
8.8
136
772
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
7.3
8.8
20
28
TQW99
NOMESCO Finland
Other minor procedure on skin
3.7
8.7
36
99
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
6.2
8.6
22
36
A06AD11
ATC
lactulose; oral
2.0
8.6
112
593
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.4
8.6
72
315
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
16.5
8.6
13
8
ZX121
NOMESCO Finland
Central venous catheter
27.8
8.5
11
*
120
Kela drug reimbursment
Hypogammaglobulinaemia
27.8
8.5
11
*
L04.9
ICD-10 Finland
Acute lymphadenitis, unspecified
20.2
8.5
12
6
L02BA01
ATC
tamoxifen; oral
20.2
8.5
12
6
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
6.1
8.5
22
37
V03AF03
ATC
calcium folinate; systemic
90.8
8.4
9
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
90.8
8.4
9
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
8.3
8
*
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
+∞
8.3
8
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
8.3
8
*
9591/3-C77.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph node, NOS
+∞
8.3
8
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
8.3
8
*
C84.59
ICD-10 Finland
Other and unspecified T-cell lymphomas
+∞
8.3
8
*
390
Kela drug reimbursment
Ibrutinib
+∞
8.3
8
*
9651/3-C77.8
ICD-O-3
Hodgkin lymphoma, lymphocyte-rich of lymph nodes of multiple regions
+∞
8.3
8
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
8.3
8
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
8.3
8
*
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
+∞
8.3
8
*
SPAT1153
SPAT
Removal of sutures
1.6
8.2
240
1644
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
4.6
8.2
27
60
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
4.9
8.1
25
52
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
33.6
8.1
10
*
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
33.6
8.1
10
*
KCD02
NOMESCO Finland
Transurethral resection of bladder
33.6
8.1
10
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
17.3
8.1
12
7
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
6.4
8.0
20
32
SPAT1255
SPAT
Intravenous administration of medicine
2.5
8.0
62
260
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.8
8.0
148
888
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.9
7.9
47
170
D44.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Thyroid gland
9.5
7.8
15
16
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
3.0
7.8
42
143
R06AE07
ATC
cetirizine; oral
1.5
7.8
375
2886
B99
ICD-10 Finland
Other and unspecified infectious diseases
5.1
7.8
23
46
D48.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other specified sites
15.2
7.7
12
8
Z10.8
ICD-10 Finland
Routine general health check-up of other defined subpopulations
2.6
7.7
53
208
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
6.0
7.7
20
34
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
7.5
7.7
17
23
6BA02
NOMESCO Finland
NA
18.5
7.6
11
6
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
4.6
7.6
25
56
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
25.2
7.6
10
*
R05
ICD-10 Finland
Cough
1.7
7.6
160
1001
TK800
NOMESCO Finland
Hemodialysis
4.2
7.5
27
66
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.3
7.4
71
329
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
80.7
7.4
8
*
HA1CM
NOMESCO Finland
Mammary gland extensive MRI examination with 3 Tesla magnet
80.7
7.4
8
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
80.7
7.4
8
*
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
80.7
7.4
8
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
80.7
7.4
8
*
J02AC03
ATC
voriconazole; systemic
80.7
7.4
8
*
B59
ICD-10 Finland
Pneumocystosis
80.7
7.4
8
*
E89.00
ICD-10 Finland
Postirradiation hypothyroidism
7.7
7.4
16
21
RS221
NOMESCO Finland
NA
5.7
7.4
20
36
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
13.5
7.4
12
9
I31.9
ICD-10 Finland
Disease of pericardium, unspecified
13.5
7.4
12
9
N05BA06
ATC
lorazepam; systemic, sublingual
2.8
7.4
45
166
WX892
NOMESCO Finland
Monitored bed care
2.2
7.3
69
321
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
+∞
7.3
7
*
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
7.3
7
*
I42.7
ICD-10 Finland
Cardiomyopathy due to drugs and other external agents
+∞
7.3
7
*
Z31.8
ICD-10 Finland
Other procreative management
+∞
7.3
7
*
C83.89
ICD-10 Finland
Other types of diffuse non-Hodgkin's lymphoma
+∞
7.3
7
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
7.3
7
*
9673/3-C42.1
ICD-O-3
Mantle cell lymphoma of bone marrow
+∞
7.3
7
*
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
+∞
7.3
7
*
9673/3-C77.9
ICD-O-3
Mantle cell lymphoma of lymph node, NOS
+∞
7.3
7
*
9659/3-C77.4
ICD-O-3
Hodgkin lymphoma, nodular lymphocyte predominant of lymph nodes of inguinal region or leg
+∞
7.3
7
*
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
+∞
7.3
7
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
7.3
7
*
L02BB03
ATC
bicalutamide; oral
+∞
7.3
7
*
2014X
ICD-9 Finland
Hodgkin's disease, Lymphocytic-histiocytic predominance[MORBUS HODGKIN,LYMPHOCYTIC PREDOMINANCE"""",NUD]
+∞
7.3
7
*
JN5JR
NOMESCO Finland
Extensive PET-CT of upper body metabolism (eyebrows to thighs)
+∞
7.3
7
*
L01XE27
ATC
[U] ibrutinib; oral
+∞
7.3
7
*
2017X
ICD-9 Finland
Hodgkin's disease, Lymphocytic depletion[MORBUS HODGKIN, LYMPHOCYTIC DEPLETION NUD]
+∞
7.3
7
*
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
7.3
7
*
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
+∞
7.3
7
*
2000B
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Reticulosarcoma[LYMPHOMA MALIGNUM DIFFUSUM]
+∞
7.3
7
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
7.3
7
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
7.3
7
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
7.3
7
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
7.3
7
*
HAE05
NOMESCO Finland
Reconstruction of breast using soft tissue and prosthesis
+∞
7.3
7
*
C84.51
ICD-10 Finland
Other and unspecified T-cell lymphomas
+∞
7.3
7
*
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.6
7.2
50
199
A06AH03
ATC
naloxegol; oral
30.2
7.2
9
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
20.2
7.1
10
5
ZXC15
NOMESCO Finland
Use of photodynamic technique
12.1
7.1
12
10
A41.8
ICD-10 Finland
Other specified sepsis
5.7
7.1
19
34
R50.8
ICD-10 Finland
Other specified fever
10.1
7.0
13
13
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
2.3
7.0
63
286
A02BC05
ATC
esomeprazole; systemic
1.5
6.9
309
2327
ZXC50
NOMESCO Finland
Cryotherapy
4.7
6.9
22
48
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
7.6
6.9
15
20
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
7.6
6.9
15
20
J01CA04
ATC
amoxicillin; systemic
1.5
6.9
725
6475
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
6.8
6.8
16
24
A02BA02
ATC
ranitidine; systemic
1.7
6.8
144
901
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
3.0
6.8
37
128
HA1DG
NOMESCO Finland
Very extensive MRI examination of mammary gland with high intensity magnet
40.3
6.8
8
*
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
40.3
6.8
8
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
16.8
6.8
10
6
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.1
6.7
71
345
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
22.7
6.7
9
*
HA1TE
NOMESCO Finland
Supplementary or limited ultrasound examination of mammary glands
22.7
6.7
9
*
EE1AA
NOMESCO Finland
X-ray of upper jaw or palate
22.7
6.7
9
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.8
6.7
115
677
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
12.3
6.6
11
9
J01MA01
ATC
ofloxacin; systemic
2.1
6.6
70
342
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
4.4
6.6
22
51
JN4DD
NOMESCO Finland
Scout CT scan of torso
70.3
6.4
7
*
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
70.3
6.4
7
*
TQW20
NOMESCO Finland
Tatoe
70.3
6.4
7
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
70.3
6.4
7
*
XX1AD
NOMESCO Finland
Other CT-examination
70.3
6.4
7
*
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
7.5
6.4
14
19
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
6.6
6.3
15
23
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
6.6
6.3
15
23
A05AA02
ATC
ursodeoxycholic acid; oral
4.2
6.3
22
53
J01MA02
ATC
ciprofloxacin; systemic
1.5
6.3
298
2258
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
11.1
6.3
11
10
ZXK00
NOMESCO Finland
Conversion from percutaneous endoscopic to open procedure
9.3
6.3
12
13
D59.1
ICD-10 Finland
Other autoimmune haemolytic anaemias
18.1
6.3
9
5
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
+∞
6.3
6
*
Y77
ICPC
Malignant neoplasm prostate
+∞
6.3
6
*
JN5PN
NOMESCO Finland
Isotope imaging of secondary neoplasms of thyroid origin
+∞
6.3
6
*
C83.33
ICD-10 Finland
Primary medical lymphoma with large B cells
+∞
6.3
6
*
JAL00
NOMESCO Finland
Biopsy of peritoneum
+∞
6.3
6
*
3AA13
NOMESCO Finland
NA
+∞
6.3
6
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
6.3
6
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
6.3
6
*
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
+∞
6.3
6
*
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
+∞
6.3
6
*
Z92.6
ICD-10 Finland
Personal history of chemotherapy for neoplastic disease
+∞
6.3
6
*
Z85.8
ICD-10 Finland
Personal history of malignant neoplasms of other organs and systems
+∞
6.3
6
*
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
6.3
6
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
6.3
6
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
6.3
6
*
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
6.3
6
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
6.3
6
*
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
+∞
6.3
6
*
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
+∞
6.3
6
*
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
+∞
6.3
6
*
L01XB01
ATC
procarbazine; oral
+∞
6.3
6
*
Z52.89
ICD-10 Finland
Donor of other organ or tissue
+∞
6.3
6
*
C18.19
ICD-10 Finland
Malignant tumor in appendix other or unspecified histology
+∞
6.3
6
*
PJ023
NOMESCO Finland
Adjuvant radiotherapy of mediastinal lymphnodes
+∞
6.3
6
*
L01CB01
ATC
etoposide; systemic
+∞
6.3
6
*
J70.1
ICD-10 Finland
Chronic and other pulmonary manifestations due to radiation
+∞
6.3
6
*
GEB30
NOMESCO Finland
Mediastinotomy and excision of lesion
+∞
6.3
6
*
C82.7
ICD-10 Finland
Other types of follicular lymphoma
+∞
6.3
6
*
1440
FHL
Mediastinoscopy
+∞
6.3
6
*
C15.5
ICD-10 Finland
Malignant neoplasm: Lower third of oesophagus
+∞
6.3
6
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
6.3
6
*
9591/3-C77.2
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of intra-abdominal lymph nodes
+∞
6.3
6
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
6.3
6
*
C84.49
ICD-10 Finland
Peripheral T-cell lymphoma, unspecified cell type
+∞
6.3
6
*
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
+∞
6.3
6
*
4704
FHL
Neck tumor removal
26.9
6.2
8
*
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
26.9
6.2
8
*
EBA10
NOMESCO Finland
Surgical removal of tooth
1.8
6.2
116
697
C07AB07
ATC
bisoprolol; oral
1.4
6.2
338
2639
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
5.4
6.2
17
32
R22.3
ICD-10 Finland
Localized swelling, mass and lump, upper limb
4.3
6.1
21
50
N02AX02
ATC
tramadol; systemic, rectal
1.4
6.1
313
2413
EMA10
NOMESCO Finland
Biopsy of tonsil
12.6
6.1
10
8
L04AD01
ATC
ciclosporin; systemic
4.0
6.0
22
56

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
611
675
19.79
307.65
7.1
2.9
u/l
232.2
235.3
0.22
593
640
(40768795) Lymph node Pathology biopsy report
263
18
193.46
307.65
1.5
1.1
—
—
—
0
0
(4035726)
344
244
20.31
307.65
1.8
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
403
708
8.53
239.03
1.5
1.5
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
202
8
310.76
204.78
1.4
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
132
50
29.98
195.35
1.5
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
449
1119
6.19
182.55
1.6
1.6
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
122
54
25.37
170.23
2.5
2.1
e9/l
1.0
1.1
0.30
93
29
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
148
107
15.89
164.31
3.0
2.7
u/ml
824.4
448.9
0.80
19
11
(3042111) Morphology [Interpretation] in Bone marrow Narrative
128
74
19.51
159.16
1.4
1.8
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
105
37
31.36
158.65
2.3
2.1
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
162
148
12.72
156.25
5.8
5.1
iu/ml
324.0
728.5
0.80
27
18
(3022096) Basophils/100 leukocytes in Blood
793
3619
5.61
147.54
9.7
5.6
%
0.7
0.7
0.29
762
3372
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
102
43
26.12
144.62
2.3
2.0
%
14.6
12.9
0.29
35
21
(3005719) IgG [Mass/volume] in Serum or Plasma
288
579
6.44
143.99
3.9
2.1
g/l
9.4
10.9
5.58
271
530
(3006315) Basophils [#/volume] in Blood
837
4043
5.93
143.56
9.8
5.5
e9/l
0.0
0.0
0.12
768
3507
(3006504) Eosinophils/100 leukocytes in Blood
803
3752
5.58
143.55
9.8
5.6
%
2.8
2.9
0.64
774
3485
(3001604) Monocytes [#/volume] in Blood
834
4025
5.88
142.95
9.8
5.4
e9/l
0.6
0.6
2.04
765
3486
(3019069) Monocytes/100 leukocytes in Blood
804
3776
5.56
142.34
10.3
5.9
%
9.2
8.5
6.91
775
3536
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
791
3712
5.35
138.86
14.2
4.0
umol/l
10.5
11.9
1.22
782
3484
(42870588) Differential panel, method unspecified - Blood
644
2590
4.74
138.39
9.3
5.5
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
843
4190
5.79
136.75
10.7
5.7
e9/l
0.2
0.2
0.48
778
3686
(3019198) Lymphocytes [#/volume] in Blood
838
4165
5.68
135.36
9.9
5.5
e9/l
1.8
1.9
0.34
773
3675
(3013650) Neutrophils [#/volume] in Blood by Automated count
872
4487
6.12
134.55
22.1
6.5
e9/l
3.5
4.2
20.07
802
3883
(3002030) Lymphocytes/100 leukocytes in Blood
805
3903
5.30
133.42
10.2
5.6
%
25.9
28.6
8.17
774
3645
(3018010) Neutrophils/100 leukocytes in Blood
798
3873
5.18
131.23
9.5
5.5
%
58.1
56.9
1.64
768
3632
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
478
1595
4.61
130.04
1.7
1.7
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
102
56
20.03
129.47
2.3
2.1
%
38.8
39.3
—
5
6
(3010503) CD19 cells [#/volume] in Blood
85
30
30.69
127.99
2.6
2.0
e9/l
0.1
0.2
0.60
85
30
(3024561) Albumin [Mass/volume] in Serum or Plasma
671
3066
4.19
114.22
7.8
4.0
g/l
35.0
36.4
7.27
660
2841
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
64
12
56.67
112.89
2.4
1.9
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
353
1048
4.54
109.36
7.2
2.9
mmol/l
0.8
0.8
1.29
347
979
(3026493) Urate [Moles/volume] in Serum or Plasma
526
2081
4.01
109.23
4.2
2.3
umol/l
1681.9
6436.0
2.84
508
1819
(40765096) Chromosome analysis panel by Banding
62
13
50.57
106.87
1.3
1.0
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
65
19
36.36
103.30
2.4
1.8
%
8.0
6.4
0.38
65
19
(21494814) CD8 cells/100 lymphocytes in Specimen
65
19
36.36
103.30
2.3
1.8
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
106
97
12.02
101.22
1.3
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
503
2030
3.79
99.40
1.9
1.9
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
216
462
5.61
98.78
2.2
1.4
g/l
1.0
1.2
2.03
202
429
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
105
101
11.42
96.93
2.1
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
121
146
9.22
94.65
2.1
1.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
467
1854
3.70
93.49
8.3
3.8
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
123
155
8.84
92.92
2.1
1.4
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
77
50
16.52
89.64
2.9
2.2
e6/l
344.0
950.6
3.01
22
18
(3027945) Reticulocytes/100 erythrocytes in Blood
272
762
4.45
89.18
4.0
2.4
%
1.7
1.7
0.15
253
677
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
112
141
8.76
84.52
1.5
1.6
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
227
584
4.67
82.60
5.3
4.2
%
1.1
0.6
2.07
128
129
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
924
6002
4.98
81.09
17.7
5.4
u/l
81.9
74.7
5.06
906
5572
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
73
52
14.99
80.79
4.0
2.6
%
39.6
46.4
0.90
19
18
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
101
118
9.35
80.78
1.6
1.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
128
198
7.21
80.77
2.2
3.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
121
179
7.49
79.49
1.4
1.4
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
624
3214
3.26
78.00
9.3
5.1
mmol/l
1.2
1.2
0.97
604
2881
(3018418) pH of Serum or Plasma
469
2048
3.30
77.67
7.3
3.2
ph
7.4
7.4
0.10
139
339
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
668
3590
3.29
77.43
10.1
5.5
mmol/l
1.2
1.2
0.12
543
3070
(3004588) Protein electrophoresis panel - Serum or Plasma
183
426
4.98
74.91
1.7
1.4
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
209
545
4.52
74.30
3.9
2.4
e9/l
68.8
70.5
0.31
175
435
(3021589) Normoblasts [#/volume] in Blood
662
3601
3.20
73.93
16.5
7.9
e9/l
0.0
0.0
0.61
565
2937
(3021440) Promyelocytes/100 leukocytes in Blood
212
564
4.44
73.39
5.2
4.3
%
0.2
0.0
2.92
117
118
(3015377) Calcium [Moles/volume] in Serum or Plasma
498
2314
3.16
73.20
7.0
2.0
mmol/l
2.4
2.3
0.59
470
1962
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
63
43
15.51
71.25
2.4
2.1
e6/l
488.1
520.1
0.11
52
35
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
335
1246
3.46
71.23
5.2
2.0
mmol/l
2.5
2.4
4.95
323
1059
(40758558) Short blood count panel - Blood
423
1819
3.19
70.60
17.9
5.0
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
110
168
7.18
70.02
1.4
1.4
u/ml
105.2
109.3
0.18
22
31
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
82
88
10.01
69.76
1.9
1.4
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
61
41
15.72
69.54
2.4
2.1
e9/l
0.2
0.2
0.21
52
34
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
80
85
10.09
68.54
1.7
1.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
60
43
14.72
66.03
1.5
1.7
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
422
1879
3.06
65.33
8.6
4.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
86
110
8.41
63.78
1.7
1.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
43
17
26.31
61.73
4.9
1.7
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
69
69
10.62
61.64
2.0
1.6
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
304
1163
3.26
60.55
2.8
1.7
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
71
76
9.94
60.41
4.0
3.0
%
1.4
0.7
1.71
62
60
(3002179) Metamyelocytes/100 leukocytes in Blood
191
540
4.09
60.29
5.1
4.1
%
0.9
0.3
2.96
89
99
(3020630) Protein [Mass/volume] in Serum or Plasma
181
508
4.09
57.58
2.6
1.6
g/l
65.9
67.3
1.14
173
465
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
71
81
9.32
57.57
1.7
1.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
188
543
3.99
57.46
5.0
4.4
%
0.0
0.9
0.52
93
103
(3042936) Bacteria identified in Isolate by Culture
279
1044
3.26
57.33
2.0
2.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
75
96
8.33
55.49
1.7
1.3
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
534
2895
2.69
54.49
11.3
8.9
inr
1.2
1.3
0.69
164
885
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
87
135
6.93
54.35
1.8
1.2
ug/l
2.5
3.1
0.77
80
125
(3013707) Erythrocyte sedimentation rate by Westergren method
872
6097
3.33
53.70
6.7
3.8
mm/h
14.4
10.4
9.31
833
5631
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
131
321
4.51
49.60
3.0
1.6
ug/l
41.3
3.7
1.31
109
244
(3003458) Phosphate [Moles/volume] in Serum or Plasma
248
936
3.15
49.54
8.4
5.6
mmol/l
1.0
1.0
0.03
238
861
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
34
13
26.98
49.22
1.2
2.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
597
3538
2.56
48.96
5.5
3.7
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
59
66
9.40
48.47
2.6
2.8
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
482
2602
2.55
47.99
2.6
1.7
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
108
232
5.07
47.95
2.4
1.7
ug/l
0.6
1.4
1.20
102
207
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
223
813
3.20
47.06
2.6
1.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
430
2252
2.52
45.01
4.0
2.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
218
815
3.10
43.84
2.5
1.7
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
154
467
3.68
43.31
2.4
1.6
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
375
1880
2.53
42.66
6.0
3.5
%
88.0
89.7
0.66
369
1827
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
39
29
13.92
41.83
2.0
1.5
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
65
98
7.00
41.58
1.2
1.3
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
129
357
3.97
41.33
1.8
1.4
iu/l
22.4
18.7
0.59
107
299
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
67
106
6.68
40.97
2.3
2.6
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
41
35
12.14
40.49
2.0
1.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
46
47
10.18
40.31
2.0
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
38
29
13.55
40.14
2.1
1.5
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
116
310
4.08
38.94
1.7
1.5
u/l
11.8
7.9
1.85
93
259
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
50
60
8.69
38.84
2.3
1.3
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
66
111
6.27
38.01
1.7
1.5
nmol/l
0.4
0.4
0.04
61
101
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
91
210
4.64
36.92
1.4
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
52
70
7.76
36.74
2.2
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
177
649
3.07
36.39
1.4
1.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
87
196
4.74
36.34
1.4
1.2
u/ml
254.3
241.8
0.14
50
120
(3048929) Epstein Barr virus Ab [Presence] in Serum
121
354
3.73
35.66
1.4
1.2
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
677
4633
2.26
35.07
8.2
4.3
mmol/l
6.6
6.7
0.45
654
4264
(44806118)
54
80
7.06
35.06
1.7
1.4
—
—
—
0
0
(44790047)
54
80
7.06
35.06
1.7
1.4
—
—
—
0
0
(44790049)
54
80
7.06
35.06
1.7
1.4
—
—
—
0
0
(44790048)
54
80
7.06
35.06
1.7
1.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
46
58
8.24
34.31
2.3
1.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
46
58
8.24
34.31
2.3
1.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
46
58
8.24
34.31
2.3
1.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
377
2061
2.28
33.80
3.8
2.9
ng/l
1524.4
1370.1
0.25
339
1718
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
105
291
3.89
33.40
1.9
1.9
g/l
1.5
1.4
0.42
87
253
(3030467) Casts [#/volume] in Urine by Automated count
375
2058
2.27
33.19
3.7
2.8
e6/l
0.7
0.3
0.71
293
1512
(3007164) IgA [Mass/volume] in Serum or Plasma
335
1754
2.33
33.16
1.8
1.3
g/l
2.1
2.4
1.27
266
1079
(3037756) Immunofixation for Serum or Plasma
58
100
6.08
32.55
1.3
1.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
398
2257
2.22
32.34
3.8
2.9
e6/l
23.5
82.2
1.24
317
1706
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
80
187
4.54
31.89
1.7
1.7
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
49
73
6.99
31.63
1.2
1.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
69
144
5.05
31.51
5.1
3.6
%
57.2
57.9
0.14
69
144
(3018095) Leukocytes [#/volume] in Urine
449
2720
2.12
30.37
4.3
3.3
e6/l
72.4
90.7
0.19
334
1849
(3030905) Polymorphonuclear cells [#/volume] in Blood
67
141
5.00
30.29
4.2
3.4
e9/l
3.8
4.4
1.47
67
141
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
326
1747
2.25
30.06
3.6
2.0
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
443
2680
2.12
29.98
3.9
2.9
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
360
2012
2.19
29.88
3.7
2.7
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
28
23
12.47
28.20
1.1
1.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
153
602
2.80
27.30
9.9
7.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
34
39
8.97
27.28
1.7
1.2
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
24
16
15.32
27.15
2.3
2.4
e6/l
116.0
231.3
—
10
8
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
172
724
2.64
26.88
4.9
2.8
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
28
26
11.03
26.08
5.3
1.2
u/l
214.2
190.0
0.42
28
26
(3002032) Base excess in Venous blood by calculation
168
709
2.62
26.07
5.3
3.3
mmol/l
2.0
1.9
0.11
142
572
(3000850) Epithelial cells [#/volume] in Urine
287
1535
2.19
26.06
2.9
2.3
e6/l
5.7
6.1
0.22
252
1321
(3000494) Fungus identified in Specimen by Culture
200
918
2.45
26.00
1.6
1.4
—
—
—
0
0
(3012501) Base excess in Blood by calculation
62
139
4.67
25.98
6.0
3.7
mmol/l
2.6
2.7
0.06
45
88
(3023199) Leukocytes [#/volume] in Pleural fluid
38
54
7.26
25.56
1.9
1.3
e6/l
1500.1
2314.4
0.73
29
37
(3008757) Leukocyte morphology finding [Identifier] in Blood
37
52
7.33
25.13
4.7
3.5
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
202
947
2.40
24.99
2.9
2.5
%
20.5
24.7
2.76
184
817
(3028308) Erythrocytes [#/volume] in Pleural fluid
36
50
7.42
24.70
1.9
1.3
e6/l
18943.2
49712.4
0.38
26
31
(3012441) Differential panel - Pleural fluid
35
48
7.50
24.28
1.9
1.3
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
28
29
9.89
24.19
3.7
6.2
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
28
29
9.89
24.19
1.9
3.1
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
149
615
2.65
24.10
9.7
7.2
mmol/l
9.1
9.2
0.08
142
585
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
182
827
2.45
24.07
7.5
2.7
umol/l
9.2
8.7
0.10
165
712
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
102
347
3.14
23.51
1.9
2.0
u/l
45.2
39.4
1.34
93
308
(3026782) Osmolality of Urine
266
1438
2.13
23.16
3.4
2.5
mosm/kgh2o
570.5
562.0
0.22
235
1197
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
146
609
2.62
23.08
2.7
2.4
g/l
0.2
0.2
2.39
131
555
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
23
19
12.35
23.02
2.9
2.0
—
—
—
0
0
(3010421) pH of Blood
66
174
3.98
22.42
5.9
3.6
ph
7.4
7.4
0.82
59
138
(40767503) Oxygen content in Capillary blood by calculation
56
133
4.39
21.84
3.3
2.5
%
15.6
16.6
0.51
21
72
(3004789) Transferrin [Mass/volume] in Serum or Plasma
207
1042
2.22
21.43
2.8
2.3
g/l
2.3
2.3
0.75
197
963
(3036481) Cortisol [Moles/volume] in Serum or Plasma
162
745
2.38
20.69
3.3
1.8
nmol/l
371.6
364.8
0.18
153
686
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
38
68
5.76
20.50
1.2
1.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
22
21
10.68
20.05
3.0
1.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
22
21
10.68
20.05
3.0
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
22
21
10.68
20.05
3.0
1.1
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
54
136
4.13
19.51
2.4
2.2
u/ml
375.3
101.9
0.75
42
107
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
63
178
3.70
19.41
1.7
1.2
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
30
45
6.83
19.20
3.0
3.3
u/ml
4697.1
994.9
1.71
30
45
(3034860) Kappa light chains.free [Mass/volume] in Serum
62
177
3.66
18.81
2.0
1.3
mg/l
65.9
48.0
0.55
44
137
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
18
0
+∞
18.80
1.2
0.0
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
62
178
3.64
18.66
2.0
1.3
mg/l
39.3
35.1
0.20
44
138
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
297
1793
1.91
18.40
1.9
1.8
mg/l
2.0
1.0
1.23
242
1312
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
25
32
7.98
18.34
1.2
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
25
32
7.98
18.34
1.2
1.6
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
431
2944
1.78
17.75
4.8
3.4
ng/l
29.5
44.4
1.83
323
1881
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
16
11
14.75
17.64
1.6
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
922
7923
2.19
17.57
26.2
9.9
ml/min/173m2
88.5
85.8
2.77
822
6296
(3022948) Iron [Moles/volume] in Serum or Plasma
211
1149
2.04
17.53
2.9
2.3
umol/l
11.8
14.2
3.99
201
1055
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
216
1187
2.03
17.49
3.6
2.6
e6/l
2.4
2.2
0.08
119
623
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
24
31
7.90
17.47
2.9
1.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
24
31
7.90
17.47
2.9
1.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
24
31
7.90
17.47
2.8
1.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
24
31
7.90
17.47
2.9
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
366
2391
1.81
17.47
1.7
1.5
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
50
132
3.92
16.96
2.1
1.3
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
21
24
8.91
16.82
1.5
1.3
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
224
1263
1.98
16.81
3.5
2.5
e6/l
0.9
0.9
0.00
130
695
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
25
37
6.89
16.19
1.2
1.4
—
—
—
0
0
(3044889) 12 lead EKG panel
707
5644
1.75
16.03
4.9
3.5
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
36
79
4.68
15.49
5.6
7.0
mg/l
9.0
11.0
1.65
30
69
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
310
1992
1.78
15.27
2.3
2.1
mg/l
3.3
2.8
2.75
281
1703
(3017354) Segmented neutrophils/100 leukocytes in Blood
28
50
5.72
15.14
4.2
3.3
%
48.6
50.7
0.13
18
33
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
963
8555
2.27
14.70
32.2
11.1
mg/l
24.4
22.1
1.39
877
6505
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
386
2670
1.70
14.47
5.4
2.8
u/l
32.9
34.1
0.20
378
2545
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
102
447
2.42
14.36
1.7
1.4
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
75
284
2.76
14.23
1.7
1.6
—
165.0
—
0
12
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
79
308
2.69
14.17
2.1
1.8
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
656
5223
1.66
14.09
5.0
3.8
e6/l
57.0
1933.9
1.97
14
74
(3035637) Corticotropin [Mass/volume] in Plasma
32
69
4.75
14.06
1.4
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
58
193
3.12
13.86
3.3
3.3
u/ml
0.3
0.3
0.25
36
107
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
355
2426
1.69
13.78
3.1
2.4
u/l
53.3
57.4
0.93
332
2243
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
17
5
34.51
13.53
1.1
1.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
28
56
5.11
13.41
1.5
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
48
146
3.40
13.26
5.6
3.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
773
6480
1.70
13.08
5.4
3.7
pmol/l
14.7
14.7
0.23
732
5918
(3000492) Spirometry study
153
836
1.97
12.33
1.8
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
71
282
2.63
12.29
1.2
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
49
160
3.16
12.10
1.2
1.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
16
20
8.11
11.90
1.7
1.6
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
56
200
2.90
11.85
1.3
1.3
g/l
0.2
0.4
0.88
48
181
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
21
36
5.93
11.83
6.3
1.1
u/ml
76.3
23.9
—
10
9
(3045788) Cell count panel - Pleural fluid
23
44
5.32
11.57
2.3
1.4
—
—
—
0
0
(3035880) pH of Pleural fluid
17
24
7.18
11.44
1.2
1.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
89
406
2.30
11.43
2.1
1.6
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
29
69
4.29
11.32
1.3
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
23
45
5.20
11.29
1.2
1.1
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
16
8
20.28
11.15
1.4
1.0
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
163
940
1.87
11.12
2.1
1.6
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
18
28
6.52
11.11
1.1
1.1
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
30
75
4.09
10.99
1.6
1.2
g/l
0.4
0.3
0.88
21
53
(3028192) IgG subclass 2 [Mass/volume] in Serum
30
75
4.09
10.99
1.6
1.2
g/l
2.3
2.8
0.59
21
53
(3027135) IgG subclass 1 [Mass/volume] in Serum
30
75
4.09
10.99
1.6
1.2
g/l
6.2
6.4
0.08
22
54
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
437
3282
1.56
10.95
2.3
2.2
nmol/l
72.5
74.8
0.93
411
2941
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
19
32
6.03
10.88
1.3
1.1
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
955
8653
1.97
10.75
29.8
12.7
mmol/l
139.3
139.7
4.43
939
8397
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
16
9
18.02
10.74
1.0
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
21
40
5.34
10.62
5.6
3.9
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
25
57
4.47
10.30
1.1
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
45
154
3.01
10.29
1.6
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
45
154
3.01
10.29
1.6
1.4
—
—
—
0
0
(3000012) Reticulocyte production index
16
24
6.75
10.20
1.5
2.0
—
—
—
0
0
(4062490)
29
75
3.95
10.17
1.6
1.2
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
954
8679
1.92
10.04
30.3
12.8
mmol/l
4.0
4.0
0.33
937
8407
(3003396) Base excess in Arterial blood by calculation
138
782
1.88
9.91
9.6
7.3
mmol/l
1.4
1.2
0.38
109
611
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
91
445
2.14
9.88
3.6
3.1
pmol/l
4.3
4.6
2.40
85
387
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
16
25
6.48
9.83
1.1
1.2
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
138
784
1.87
9.83
9.6
7.2
kpa
11.3
11.8
0.72
133
756
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
138
784
1.87
9.83
9.7
7.3
kpa
5.0
5.1
0.47
133
756
(3025941) Bacteria identified in Stool by Culture
93
460
2.12
9.80
1.5
1.2
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
39
127
3.15
9.71
1.6
1.7
g/l
0.7
0.9
0.51
31
98
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
57
229
2.57
9.67
1.3
1.3
g/l
10.7
10.9
0.06
51
200
(3026389) Candida sp identified in Specimen by Organism specific culture
30
83
3.69
9.59
1.2
1.2
—
—
—
0
0
(3013512) EKG study
304
2159
1.57
9.45
5.0
3.6
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
14
8
17.71
9.41
4.6
1.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
30
85
3.60
9.27
1.1
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
105
557
1.98
9.16
3.0
2.5
e9/l
3.8
4.2
0.95
85
432
(3024932) HLA-DR beta [Type]
16
27
6.00
9.14
1.6
1.1
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
59
249
2.45
9.05
1.3
1.3
g/l
7.5
7.3
0.28
47
190
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
59
249
2.45
9.05
1.3
1.3
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
59
249
2.45
9.05
1.3
1.3
g/l
3.8
3.9
0.14
46
181
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
223
1487
1.63
8.98
4.6
3.6
ng/l
310.9
642.0
1.11
174
1104
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
37
123
3.08
8.92
1.2
1.6
—
—
—
0
0
(3024471) HLA-A [Type]
16
28
5.79
8.82
1.1
1.0
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
44
165
2.74
8.57
2.9
2.3
g/l
119.6
132.5
1.41
25
123
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
23
57
4.10
8.55
2.5
1.9
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
31
95
3.33
8.53
3.0
2.7
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
104
566
1.93
8.42
1.4
1.3
u/ml
315.4
240.3
0.26
88
526
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
64
292
2.27
8.25
2.9
1.6
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
985
9160
1.96
8.18
20.1
8.3
u/l
27.9
27.6
0.21
971
8810
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
41
152
2.77
8.17
1.2
1.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
664
5644
1.47
8.16
5.0
3.8
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
51
213
2.46
8.02
4.3
3.2
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
54
232
2.40
7.99
1.3
1.3
g/l
3.4
3.0
1.65
46
185
(3028679) Herpes simplex virus Ab [Presence] in Serum
19
43
4.48
7.92
1.3
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
39
144
2.77
7.84
1.2
1.1
—
—
—
0
0
(3019225) pH of Specimen
121
709
1.80
7.77
5.3
3.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
165
1060
1.66
7.62
1.4
1.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
288
2107
1.50
7.56
3.3
2.7
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
88
474
1.93
7.36
4.2
3.2
mmol/l
2.4
1.7
0.88
67
346
(3037522) Nuclear Ab [Titer] in Serum
175
1151
1.62
7.35
1.4
1.4
titre
314.4
515.4
2.50
36
243
(3009343) pH of Capillary blood
90
491
1.91
7.25
4.2
3.2
ph
7.4
7.4
2.34
15
61
(3051611) Lipemic interference index of Serum or Plasma
23
65
3.59
7.17
5.4
3.5
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
11
16
6.94
7.16
3.4
4.7
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
10
5
20.17
7.14
1.0
5.4
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
10
13
7.76
7.13
2.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
10
13
7.76
7.13
2.1
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
10
13
7.76
7.13
2.1
1.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
21
56
3.81
7.10
1.1
1.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
21
56
3.81
7.10
1.2
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
35
129
2.77
7.08
1.3
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
66
326
2.09
7.02
1.3
1.4
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
23
66
3.54
7.02
1.1
1.2
u/l
57.4
54.8
0.07
18
44
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
117
701
1.75
6.97
3.1
2.3
u/l
38.5
35.1
0.25
100
600
(40768441) Liver Pathology biopsy report
19
48
4.01
6.91
1.2
1.6
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
22
62
3.60
6.89
1.2
1.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
465
3783
1.41
6.77
3.5
2.8
ug/l
267.2
111.0
6.86
447
3510
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
10
6
16.81
6.75
1.6
6.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
14
28
5.05
6.71
1.7
1.6
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
89
498
1.86
6.64
4.3
3.2
kpa
5.1
5.2
0.04
84
467
(3006922) Hepatitis E virus Ab [Presence] in Serum
20
55
3.69
6.49
1.1
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
20
55
3.69
6.49
1.6
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
112
678
1.73
6.43
4.4
3.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
35
137
2.61
6.33
1.1
1.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
858
7827
1.49
6.15
6.2
4.3
mu/l
2.1
2.2
0.04
815
7217
(3004451) EKG impression Narrative
15
35
4.33
6.03
1.1
1.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
33
130
2.59
5.91
3.4
2.5
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
50
239
2.15
5.83
1.3
1.2
titre
114.2
87.7
0.46
12
30
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
28
102
2.79
5.82
1.2
1.3
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
10
9
11.20
5.80
1.1
1.2
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
89
520
1.78
5.79
3.7
4.2
ng/l
88.4
87.5
0.03
74
464
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
54
267
2.08
5.77
2.0
1.6
—
—
—
0
0
(3020891) Body temperature
56
284
2.03
5.60
5.3
4.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
50
252
2.03
5.11
1.4
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
62
337
1.89
5.11
1.3
1.3
miu/ml
142.0
233.8
1.20
18
160
(3021960) Folate [Moles/volume] in Serum or Plasma
240
1816
1.41
5.05
1.6
1.5
nmol/l
19.1
20.7
0.97
215
1564
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
32
135
2.41
5.01
1.1
1.2
u/l
81.9
19.4
1.09
26
116
(3014765) Yersinia sp identified in Stool by Organism specific culture
50
254
2.02
5.00
1.4
1.1
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
67
378
1.82
4.92
2.8
2.5
e6/l
0.4
0.2
1.58
67
367
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
302
2385
1.37
4.91
2.1
2.1
u/l
163.9
276.4
1.75
292
2243
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
17
51
3.37
4.90
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
17
51
3.37
4.90
1.1
1.0
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
50
257
1.99
4.85
1.4
1.2
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
9
10
9.06
4.79
1.1
1.0
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
10
20
5.04
4.78
2.3
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
10
20
5.04
4.78
2.3
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
77
459
1.73
4.71
6.7
5.4
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
190
1396
1.44
4.68
1.7
1.7
nmol/l
1130.4
1170.0
0.28
162
1083
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
10
21
4.80
4.54
2.1
1.1
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
10
22
4.58
4.31
2.3
3.3
—
—
—
0
0
(4281824)
12
32
3.78
4.09
1.2
1.1
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
8
10
8.05
4.06
1.0
1.8
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
13
37
3.54
4.06
1.4
1.8
—
1903858.3
—
0
6
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
14
42
3.36
4.05
1.1
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
23
93
2.51
3.98
2.4
2.2
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
23
94
2.48
3.90
2.4
2.2
mmol/l
4.3
4.1
0.81
23
94
(3035285) Chloride [Moles/volume] in Venous blood
23
94
2.48
3.90
2.4
2.2
mmol/l
105.7
105.3
0.12
23
94
(3022313) Gas panel - Capillary blood
61
362
1.73
3.84
4.2
3.4
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
15
49
3.09
3.81
1.1
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
10
25
4.03
3.70
2.3
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
10
25
4.03
3.70
2.4
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
672
6087
1.28
3.67
3.5
3.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
91
605
1.55
3.67
2.5
2.1
ml/min/173m2
66.1
71.1
0.56
37
227
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
42
227
1.88
3.59
1.1
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
22
92
2.42
3.57
1.1
1.0
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
643
5803
1.27
3.57
3.8
3.0
u/l
56.8
44.4
3.20
609
5438
(3003327) Ova and parasites identified in Stool by Light microscopy
50
287
1.78
3.54
2.2
1.8
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
158
1181
1.40
3.52
1.5
1.7
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
6
6
10.05
3.50
1.5
2.7
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
26
119
2.21
3.46
1.8
2.6
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
59
359
1.68
3.42
14.2
10.5
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
6
210
0.28
3.36
1.2
1.5
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
98
676
1.50
3.35
2.2
2.4
ug/l
6.8
7.7
0.28
88
597
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
376
3202
1.27
3.34
1.9
1.9
pmol/l
90.7
94.9
1.21
210
1693
(3017446) Testosterone [Moles/volume] in Serum or Plasma
103
719
1.48
3.32
2.4
2.3
nmol/l
12.3
14.2
1.94
98
644
(3037121) Protein [Mass/volume] in Urine
46
266
1.76
3.20
2.6
2.6
g/l
0.9
0.3
0.69
21
104
(40761539) Cells [Type] in Urine sediment by Light microscopy
8
15
5.36
3.19
1.0
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
42
237
1.80
3.17
1.3
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
113
812
1.44
3.15
1.4
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
40
223
1.82
3.14
3.0
1.7
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
27
131
2.09
3.14
1.8
1.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
41
231
1.81
3.12
1.2
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
75
497
1.55
3.10
1.4
1.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
86
589
1.50
3.06
1.2
1.2
iu/ml
93.3
137.5
0.47
19
247
(3010937) Rubella virus Ab [Presence] in Serum
6
8
7.53
3.05
1.0
1.1
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
6
8
7.53
3.05
1.2
1.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
8
16
5.03
3.05
1.3
1.0
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
13
45
2.91
3.03
1.4
1.4
u/l
11.7
5.2
—
6
18
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
5
5
10.04
2.98
1.0
1.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
30
155
1.96
2.97
2.4
1.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
459
4042
1.24
2.95
4.2
3.2
estimate
0.0
0.0
0.00
109
722
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
11
35
3.17
2.93
5.0
2.1
nmol/l
3.5
2.7
0.31
11
35
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
26
128
2.06
2.93
1.1
1.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
65
424
1.57
2.89
2.2
2.3
u/l
4166.9
4345.9
0.03
22
179
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
15
58
2.61
2.88
1.7
1.5
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
7
13
5.41
2.87
1.3
1.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
458
4044
1.23
2.84
5.8
4.4
estimate
0.0
0.0
0.50
111
739
(3001019) Free T4 and TSH panel - Serum or Plasma
70
469
1.53
2.78
1.7
1.6
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
31
168
1.87
2.69
3.1
3.3
umol/l
40.3
34.2
0.65
24
146
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
223
1836
1.27
2.54
1.6
1.6
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
36
210
1.74
2.49
1.6
1.3
e6/l
5.3
736.5
0.82
29
175
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
36
210
1.74
2.49
1.6
1.2
e6/l
4.8
43.4
0.79
28
170
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
824
8644
0.80
2.48
4.5
4.6
mmol/l
2.7
2.8
0.91
766
8040
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
36
211
1.73
2.45
1.3
1.3
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
47
297
1.61
2.43
1.7
1.6
iu/ml
1.0
0.1
0.53
13
56
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
12
279
0.42
2.40
1.5
1.5
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
6
12
5.02
2.40
2.0
1.1
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
9
27
3.35
2.39
2.2
1.1
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
5
8
6.27
2.37
1.8
2.8
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
7
17
4.14
2.36
1.3
1.1
%
105.7
108.8
—
7
17
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
7
17
4.14
2.36
1.3
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
25
133
1.90
2.32
1.1
1.2
—
—
—
0
0
(4094501)
38
231
1.67
2.29
1.0
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
31
178
1.76
2.28
5.0
2.6
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
6
13
4.63
2.27
1.5
1.2
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
7
18
3.91
2.25
8.4
4.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
455
4094
1.19
2.16
4.3
3.2
estimate
0.0
0.0
0.50
108
708
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
16
74
2.18
2.15
1.8
1.3
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
120
935
1.32
2.09
22.8
23.6
inr
1.2
1.3
0.68
20
144
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
5
10
5.02
2.07
1.8
2.5
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
5
10
5.02
2.07
1.0
2.5
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
5
10
5.02
2.07
1.6
2.8
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
29
169
1.74
2.05
1.4
1.1
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
16
76
2.12
2.03
1.1
1.6
mosm/kgh2o
280.4
280.5
—
9
55
(3000570) Elastase.pancreatic [Mass/mass] in Stool
31
185
1.70
2.02
1.6
1.4
ug/g
260.8
330.0
1.17
21
105
(3002523) Influenza virus A Ag [Presence] in Specimen
29
170
1.73
2.02
1.4
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
240
2044
1.22
2.01
1.3
1.3
u/ml
0.7
1.7
2.71
57
573
(40761511) CBC panel - Blood by Automated count
938
9060
1.29
1.99
22.7
10.6
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
810
8463
0.82
1.97
4.0
4.1
mmol/l
1.4
1.4
3.04
756
7875
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
9
34
2.66
1.86
1.1
1.1
u/l
126.2
68.0
—
9
23
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
9
34
2.66
1.86
1.1
1.1
u/l
55.7
17.4
—
9
22
(3044290) Cell count panel - Cerebral spinal fluid
30
182
1.67
1.86
1.5
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
30
182
1.67
1.86
5.1
4.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
46
2.41
1.85
1.2
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
120
1493
0.78
1.83
2.1
2.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
14
66
2.14
1.82
1.6
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
846
8101
1.21
1.81
29.2
12.0
%
39.3
40.7
5.40
633
6093
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
108
1358
0.77
1.79
1.9
2.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
14
67
2.10
1.76
1.6
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
5
13
3.86
1.71
1.8
2.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
14
68
2.07
1.70
3.4
3.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
217
1860
1.21
1.70
4.1
3.1
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
5
14
3.58
1.61
1.0
1.1
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
17
91
1.88
1.61
5.0
6.4
mmol/l
6.6
7.1
0.40
12
75
(3005082) Progesterone [Moles/volume] in Serum or Plasma
10
43
2.34
1.60
1.6
1.2
nmol/l
32.4
30.7
—
10
37
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
51
364
1.42
1.58
1.0
1.1
u/ml
—
1.9
—
0
7
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
19
107
1.79
1.55
1.1
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
52
374
1.41
1.55
4.6
3.2
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
8
33
2.43
1.54
1.6
2.6
ug/l
1.0
1.7
—
8
28
(3024869) Neuronal Ab [Presence] in Serum
5
15
3.34
1.52
1.0
1.1
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
6
21
2.87
1.50
1.2
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
6
21
2.87
1.50
1.5
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
14
72
1.96
1.49
1.5
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
40
276
1.47
1.49
2.0
2.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
245
2151
1.18
1.47
4.8
3.4
estimate
0.0
0.0
1.08
106
719
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
30
195
1.55
1.47
1.5
1.8
iu/l
1.5
5.4
—
10
65
(3043410) Blood group antigens tested for on Red Blood Cells
6
22
2.74
1.43
2.7
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
739
7717
0.86
1.43
5.6
5.5
mmol/mol
40.2
39.4
1.24
691
7213
(1002224) Polysomnography panel
26
399
0.64
1.43
1.0
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
15
81
1.86
1.40
1.1
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
116
953
1.24
1.39
10.4
6.1
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
13
67
1.95
1.38
1.2
1.0
u/l
1.3
1.0
—
6
33
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
34
231
1.49
1.38
1.2
1.2
u/ml
5.2
6.5
—
5
33
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
5
17
2.95
1.36
1.0
1.1
—
76.2
—
0
6
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
5
17
2.95
1.36
1.0
1.1
—
87.7
—
0
7
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
29
191
1.53
1.35
1.3
1.2
u/ml
23.8
36.4
—
6
15
(3051387) C reactive protein [Mass/volume] in Capillary blood
28
184
1.54
1.33
5.0
3.6
mg/l
28.7
24.4
0.35
19
130
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
15
83
1.82
1.31
3.7
1.2
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
40
284
1.42
1.31
2.7
2.3
ug/l
483.2
453.6
0.04
34
262
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
9
43
2.10
1.30
1.1
1.0
miu/ml
490.6
1586.9
—
9
43
(3005988) Vibrio sp identified in Specimen by Organism specific culture
15
84
1.80
1.27
3.7
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
15
84
1.80
1.27
3.7
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
14
242
0.57
1.27
2.1
1.7
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
825
8519
0.86
1.24
4.1
4.2
mmol/l
4.6
4.6
0.93
777
7958
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
8
37
2.17
1.21
1.4
1.6
umol/l
25.0
28.3
—
8
37
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
15
86
1.75
1.19
3.7
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
15
86
1.75
1.19
3.7
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
15
86
1.75
1.19
3.7
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
19
117
1.64
1.18
2.2
1.6
—
—
—
0
0
(3012565) Volume of 24 hour Urine
8
38
2.11
1.18
2.3
2.1
ml
1635.0
2215.6
—
8
33
(3041096) Erythrocytes [Presence] in Urine by Automated
252
2256
1.15
1.18
3.9
2.9
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
15
245
0.61
1.12
1.7
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
82
1001
0.80
1.11
1.2
1.3
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
10
51
1.97
1.11
1.1
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
14
81
1.74
1.09
1.4
1.2
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
12
66
1.83
1.09
1.7
2.6
mg/l
23.7
24.1
—
6
18
(3023410) Appearance of Cerebral spinal fluid
15
89
1.70
1.08
1.4
1.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
5
22
2.28
1.03
1.2
1.2
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
5
22
2.28
1.03
7.8
6.4
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
11
60
1.84
1.03
1.0
1.0
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
7
34
2.07
1.03
2.0
1.7
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
7
134
0.52
0.99
9.4
5.8
umol/l
398.9
369.7
—
7
116
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
7
36
1.95
0.97
1.6
1.5
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
10
54
1.86
0.96
3.0
1.3
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
10
54
1.86
0.96
1.2
1.3
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
9
50
1.81
0.96
1.0
1.1
—
—
—
0
0
(4027681)
12
69
1.75
0.96
1.3
1.3
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
0
31
0.00
0.96
0.0
2.4
—
9.1
—
0
26
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
12
70
1.72
0.92
1.1
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
338
3131
1.12
0.92
4.6
3.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
49
619
0.78
0.92
1.2
1.4
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
10
55
1.83
0.92
1.4
2.0
—
1.0
—
0
6
(40761535) Cells panel - Urine sediment
75
619
1.23
0.92
4.2
2.9
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
851
8284
1.13
0.91
4.7
4.2
mmol/l
5.9
5.9
0.10
791
7603
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
10
56
1.79
0.88
1.1
1.2
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
8
43
1.87
0.87
1.5
2.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
990
9751
1.21
0.86
42.8
16.2
e9/l
249.8
249.9
0.02
974
9477
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
11
64
1.73
0.86
1.7
1.6
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
8
44
1.82
0.86
2.3
1.6
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
13
80
1.63
0.84
1.5
1.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
13
80
1.63
0.84
1.4
1.5
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
6
31
1.94
0.84
1.7
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
8
45
1.78
0.84
1.1
1.2
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
8
45
1.78
0.84
1.0
1.3
nmol/l
130.4
147.7
—
8
45
(3045424) Erythrocytes [Presence] in Urine
19
129
1.48
0.83
1.7
1.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
29
387
0.74
0.83
1.2
1.4
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
6
32
1.88
0.82
1.5
1.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
54
662
0.81
0.81
1.6
1.9
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
30
396
0.75
0.80
1.3
1.8
mg/l
5.1
3.1
1.08
23
270
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
27
362
0.74
0.80
1.7
1.9
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
20
139
1.45
0.79
1.0
1.1
—
14.6
—
0
10
(3024731) MCV [Entitic volume]
990
9760
1.19
0.79
42.6
16.2
fl
90.4
90.5
0.27
983
9609
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
6
33
1.82
0.79
1.2
1.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
205
2250
0.89
0.79
1.8
1.6
mmol/l
1.5
1.4
0.54
180
1912
(3035941) MCH [Entitic mass]
990
9761
1.19
0.78
42.5
16.1
pg
30.0
30.3
4.37
983
9609
(3026361) Erythrocytes [#/volume] in Blood
990
9762
1.19
0.78
42.7
16.2
e12/l
4.4
4.6
23.61
974
9472
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
27
0.00
0.77
0.0
1.3
—
9.4
—
0
27
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
18
256
0.70
0.76
1.7
1.4
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
6
34
1.77
0.76
1.8
2.5
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
990
9765
1.19
0.75
42.7
16.2
e9/l
6.6
6.7
0.63
972
9470
(3000963) Hemoglobin [Mass/volume] in Blood
990
9766
1.19
0.75
43.0
16.3
g/l
130.5
138.2
40.94
983
9613
(3035320) C reactive protein [Mass/volume] in Body fluid
9
55
1.64
0.73
2.8
2.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
49
598
0.81
0.72
1.3
1.5
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
13
84
1.55
0.72
1.6
2.1
nmol/l
17.8
21.9
0.90
13
75
(3017569) Oxygen content in Arterial blood
7
40
1.75
0.71
3.3
1.7
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
77
896
0.85
0.69
1.6
1.7
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
10
156
0.64
0.67
1.4
1.1
u/ml
1.7
3.2
—
5
45
(3048689) Calprotectin [Mass/mass] in Stool
124
1104
1.14
0.67
2.1
2.5
ug/g
136.9
129.7
0.10
105
870
(3045414) Leukocytes [Presence] in Urine
42
339
1.25
0.67
1.7
1.6
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
33
417
0.78
0.67
1.2
2.2
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
5
28
1.79
0.66
3.0
1.3
pmol/l
13.7
13.0
—
5
23
(3042733) HLA Ab [Presence] in Serum
5
28
1.79
0.66
5.8
4.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
7
44
1.59
0.65
2.1
2.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
44
535
0.81
0.64
1.3
2.2
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
27
207
1.31
0.64
2.6
2.3
ug/min
179.4
109.0
0.30
16
131
(3021788) Differential panel - Synovial fluid
19
138
1.38
0.62
1.9
1.6
—
—
—
0
0
(3011648) Oxygen content in Venous blood
11
71
1.56
0.62
5.5
1.9
%
12.3
11.0
0.87
11
71
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
0
20
0.00
0.60
0.0
1.9
—
8.7
—
0
12
(4034850)
22
288
0.76
0.59
14.5
10.4
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
22
0.00
0.59
0.0
1.7
—
16.0
—
0
22
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
10
64
1.57
0.58
1.6
1.5
g/l
1.0
1.0
—
10
64
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
10
150
0.66
0.58
1.1
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
41
495
0.82
0.57
1.2
2.3
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
6
35
1.72
0.57
1.2
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
13
184
0.70
0.57
1.4
1.1
u/ml
0.7
2.3
—
6
83
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
6
36
1.67
0.56
1.0
1.0
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
6
38
1.58
0.54
1.0
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
18
134
1.35
0.53
1.3
1.2
u/ml
2.4
5.7
—
8
62
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
6
39
1.54
0.53
1.0
2.7
ug/l
18.9
229.0
—
6
34
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
182
1685
1.10
0.52
1.7
1.7
pmol/l
420.8
31616514.2
1.98
158
1417
(3027008) Opiates [Presence] in Urine
45
532
0.84
0.52
1.3
2.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
72
819
0.87
0.52
1.9
2.0
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
12
168
0.71
0.50
1.3
1.1
u/ml
19.5
6.5
—
7
98
(3027944) Amphetamines [Presence] in Urine
45
526
0.85
0.47
1.3
2.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
800
8137
0.93
0.43
3.9
3.8
mmol/l
1.3
1.3
0.72
749
7526
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
14
104
1.35
0.43
1.1
1.0
—
—
—
0
0
(4146454)
6
93
0.64
0.42
2.8
2.8
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
133
1438
0.91
0.42
1.2
1.3
iu/ml
43.5
28.7
0.42
35
441
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
31
258
1.21
0.42
1.9
1.5
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
33
1.52
0.41
1.0
1.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
175
1865
0.93
0.40
4.6
3.4
kg/l
1.0
1.0
0.36
23
255
(3008401) Mugwort IgE Ab [Units/volume] in Serum
12
160
0.75
0.40
1.3
1.1
u/ml
0.7
2.1
—
6
78
(44813793)
8
61
1.31
0.39
1.0
1.0
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
46
527
0.87
0.39
1.3
2.3
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.1
—
0.2
—
0
5
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
223
2350
0.94
0.38
3.8
3.5
%
21.3
23.7
1.45
115
1013
(3017817) Protein [Mass] in Urine collected for unspecified duration
9
68
1.33
0.37
3.3
1.8
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
5
37
1.35
0.37
3.0
2.5
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
15
116
1.30
0.37
1.1
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
128
1376
0.92
0.37
1.2
1.2
u/ml
7.4
11.3
0.27
38
538
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
11
81
1.36
0.36
1.0
2.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
312
3240
0.95
0.33
2.8
2.7
—
—
—
0
0
(3024263) Appearance of Synovial fluid
6
46
1.31
0.33
2.0
1.8
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
21
174
1.21
0.31
1.8
1.8
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
7
52
1.35
0.31
1.1
1.1
—
16.4
—
0
8
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
91
983
0.92
0.31
3.9
4.3
%
31.4
31.5
0.01
67
677
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
14
111
1.26
0.30
1.1
1.1
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
16
130
1.23
0.29
1.0
1.1
u/ml
1.7
2.8
—
9
61
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
11
85
1.30
0.28
1.3
1.5
mmol/l
11.2
13.0
—
6
17
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
131
1236
1.07
0.27
1.6
1.8
%
1.4
1.5
0.46
118
1100
(3019897) Erythrocyte distribution width [Ratio] by Automated count
10
128
0.78
0.27
3.3
2.8
%
13.6
13.1
—
10
128
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
11
138
0.79
0.25
1.4
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
134
1271
1.06
0.25
1.5
1.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
53
484
1.10
0.24
1.0
1.0
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
68
733
0.92
0.23
1.1
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
16
134
1.20
0.23
1.1
1.2
—
—
—
0
0
(3017704) Immunofixation for Urine
5
39
1.28
0.23
1.0
1.2
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
30
266
1.13
0.22
1.3
1.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
7
93
0.75
0.22
1.1
1.3
nmol/l
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
21
242
0.87
0.22
1.2
2.9
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
30
267
1.13
0.22
1.3
1.4
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
11
0.00
0.21
0.0
5.5
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.6
—
98.5
—
0
11
(3013762) Body weight Measured
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
60
556
1.08
0.21
1.1
1.2
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
12
98
1.23
0.21
1.4
1.1
%
82.2
94.7
0.64
12
93
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
12
0.00
0.21
0.0
3.7
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
8
103
0.78
0.21
1.3
1.3
nmol/l
0.6
0.6
—
8
96
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
6
49
1.23
0.20
1.0
1.4
—
18.8
—
0
12
(4024509)
6
52
1.15
0.19
2.3
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
40
366
1.10
0.19
2.3
2.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
32
353
0.90
0.19
1.1
1.1
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
6
53
1.13
0.18
1.0
1.6
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
24
213
1.13
0.18
2.2
1.4
—
—
—
0
0
(4010399)
52
559
0.93
0.18
1.5
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
47
506
0.93
0.17
2.5
2.5
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
13
152
0.85
0.17
1.6
1.5
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
8
70
1.14
0.16
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
8
70
1.14
0.16
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
8
70
1.14
0.16
1.1
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
16
139
1.15
0.16
1.3
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
8
71
1.13
0.16
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
8
71
1.13
0.16
1.1
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
8
71
1.13
0.16
1.1
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
8
71
1.13
0.16
1.1
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
30
274
1.10
0.15
1.4
1.5
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
9
83
1.09
0.14
1.2
1.0
mg/l
331.8
282.6
—
9
76
(3027456) Digoxin [Moles/volume] in Serum or Plasma
14
122
1.15
0.13
3.5
3.1
nmol/l
0.7
0.8
—
9
93
(44816559) Phosphatidylethanol [Mass/volume] in Blood
25
229
1.09
0.12
1.4
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
249
2441
1.03
0.12
4.4
4.2
mg/mmol
8.5
9.4
0.16
172
1601
(3014133) Dog dander IgE Ab [Units/volume] in Serum
12
137
0.87
0.12
1.2
1.1
u/ml
7.3
3.7
—
6
56
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
104
1076
0.96
0.12
2.0
1.8
—
—
—
0
0
(4268621)
11
95
1.16
0.11
2.1
2.2
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
5
46
1.09
0.09
1.0
1.3
—
292.0
—
0
5
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
5
46
1.09
0.09
1.0
1.3
—
64.0
—
0
5
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
5
47
1.06
0.09
3.4
2.3
umol/l
70.0
51.6
—
5
39
(3025577) Chromium [Mass/volume] in Blood
5
47
1.06
0.09
2.4
1.9
ug/l
2.7
1.7
—
5
38
(3026470) Cobalt [Mass/volume] in Blood
5
48
1.04
0.09
1.6
1.9
ug/l
2.9
2.7
—
5
43
(4198724)
6
55
1.09
0.09
1.2
1.9
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
22
204
1.08
0.08
1.6
1.6
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
5
60
0.83
0.08
1.2
1.1
—
60.2
—
0
6
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
5
62
0.81
0.08
1.2
1.1
—
70.4
—
0
7
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
34
322
1.06
0.08
1.3
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
34
323
1.05
0.07
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
34
323
1.05
0.07
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
34
323
1.05
0.07
1.3
1.4
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
8
74
1.08
0.07
1.4
1.1
nmol/l
370.9
400.2
—
8
66
(3032773) Endomysium IgG Ab [Titer] in Serum
7
84
0.83
0.07
1.0
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
236
2329
1.02
0.07
3.5
3.4
mg/l
260.3
216.2
0.08
163
1525
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
91
0.88
0.06
1.3
1.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
35
365
0.96
0.06
1.5
3.0
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
16
172
0.93
0.06
1.6
1.7
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
29
304
0.95
0.05
1.7
1.6
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
26
248
1.05
0.05
1.0
1.1
u/ml
4.0
6.9
—
7
33
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
291
2933
0.99
0.04
4.1
3.6
ug/l
2.0
1.8
0.43
260
2640
(3023430) Cat dander IgE Ab [Units/volume] in Serum
11
119
0.92
0.04
1.2
1.1
u/ml
5.3
6.2
—
5
54
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
107
1055
1.02
0.03
1.6
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
168
1664
1.01
0.03
2.8
2.6
ug/l
0.7
0.7
0.13
113
1028
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
36
351
1.03
0.02
1.5
1.8
nmol/l
42.8
38.8
0.57
36
335
(3044941) Cell count panel - Synovial fluid
12
126
0.95
0.00
1.9
1.4
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
14
146
0.96
0.00
1.1
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
263
2637
1.00
0.00
3.3
3.3
mmol/l
7.8
8.2
0.69
218
2242
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
25
254
0.98
0.00
1.8
1.9
pmol/l
203.0
215.0
0.16
25
242
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
36
357
1.01
0.00
1.3
1.5
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
15
145
1.03
0.00
2.5
2.5
umol/l
6.5
5.0
—
10
105
(4306422)
14
135
1.04
0.00
1.4
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
7
77
0.91
0.00
1.0
1.1
—
—
—
0
0
(3051339) Copper [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.1
—
15.2
—
0
7
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
5
51
0.98
0.00
1.2
1.1
iu/ml
343.8
231.9
—
5
51
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
1.4
—
0
6
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
386.3
—
0
6
(3041672) Baker's yeast Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.5
—
46.1
—
0
6
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
36.0
—
0
9
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
7.7
—
0
5
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
9
0.00
0.00
0.0
5.3
—
—
—
0
0
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
6
62
0.97
0.00
1.7
1.5
—
72.0
—
0
5
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
1.5
—
0
5
(3016330) Potassium [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3025315) Body weight
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
3.2
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
7
70
1.00
0.00
1.7
1.5
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
9
96
0.94
0.00
1.1
1.2
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: CD2_HODGKIN_LYMPHOMA_EXALLC – Hodgkin lymphoma

GWS hits: 1

This endpoint is excluded (different definition than used in FinnGen).